Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07671755
NA
Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment
Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma
View on ClinicalTrials.gov
Summary
This study aims to evaluate clinical outcomes of colistin versus colistin in combination with cefoperazone-sulbactam for patients with MDR-AB VAP treatment.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-02-01
Completion Date
2026-04-30
Last Updated
2026-06-26
Healthy Volunteers
No
Conditions
Interventions
DRUG
colistin plus cefoperazone-sulbactam combination group
Combination therapy
DRUG
Colistin
Monotherapy
Locations (1)
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Karachi, Pakistan